Skip to Content
Stock Analyst Update

Coronavirus Could Take a Bite Out of Carnival's Results

The narrow-moat firm has updated the financial impact that it expects to its business.

Mentioned:

With the spread of the coronavirus failing to abate, narrow-moat Carnival (CCL) has updated the financial impact that it expects to its business. In its 10-K, the company noted nine canceled cruises through Feb. 4, when Carnival anticipated a $0.03-$0.04 earnings per share impact. It further noted that had China cruises been canceled through the end of February, it would cost the firm another $0.05-$0.06 per share (totaling about a dime for all of February). However, now that the spread of the virus has permeated other countries in Asia, cancellations are occurring outside of China. Carnival has offered that if it ceased operations in Asia until the end of April, this would act as a $0.55-$0.65 drag to 2020 EPS, leading to a potential 10% decline in year-over-year 2020 EPS. This was based on inaugural guidance of $4.30-$4.60 in EPS (and our $4.57 estimate).

If we alter our model to incorporate the full effect of cancellations in Asia through April, our $58 fair value estimate fails to change materially, when we assume 2021 returns to the same yields and costs per diem as prior to the update. We remind investors not to hit the panic button, as in the year following SARS (the next year was 2004), H1N1 (2010), and Zika (2017), Carnival and Royal both posted positive as-reported yield growth, conveying the resilience of demand across the industry. We also assume that if the coronavirus continues on a protracted path, Carnival will begin to redeploy its hardware to attempt to capture some positive economics off of the currently waylaid fleet. We plan no change to our long-term outlook for Carnival, which incorporates 1.8% average yield and 0.7% average cost growth in 2021 and beyond. This ultimately drives 31% terminal EBITDA margins at the business.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Jaime M. Katz does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.